Evidence map›Paper›PMID 24625780›Full record

ArticleNature protocols2014

Germline transgenesis in pigs by cytoplasmic microinjection of Sleeping Beauty transposons.

Zoltán Ivics, Wiebke Garrels, Lajos Mátés, Tien Yin Yau, Sanum Bashir, Vaclav Zidek, Vladimír Landa, Aron Geurts, Michal Pravenec, Thomas Rülicke and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Engineering Large Animal Species to Model Human Diseases.Current protocols in human genetics · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

Zoltán Ivics1] Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany. [2].
Wiebke Garrels1] Friedrich-Loeffler-Institut, Institut für Nutztiergenetik, Neustadt, Germany. [2].
Lajos MátésBiological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Tien Yin YauInstitute of Laboratory Animal Science, University of Veterinary Medicine Vienna, Vienna, Austria.
Sanum BashirMax Delbrück Center for Molecular Medicine, Berlin, Germany.
Vaclav ZidekInstitute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Vladimír LandaInstitute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Aron GeurtsDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Michal PravenecInstitute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Thomas RülickeInstitute of Laboratory Animal Science, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID 0000000221219496
Wilfried A KuesFriedrich-Loeffler-Institut, Institut für Nutztiergenetik, Neustadt, Germany.
Zsuzsanna IzsvákMax Delbrück Center for Molecular Medicine, Berlin, Germany.
Czech Academy of Sciences · CZFriedrich-Loeffler-Institut · DEMax Delbrück Center · DEUniversity of Veterinary Medicine Vienna · ATHUN-REN Szegedi Biológiai Kutatóközpont · HUMedical College of Wisconsin · USPaul Ehrlich Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pig has emerged as an important large animal model in biomedical and pharmaceutical research. We describe a protocol for high-efficiency germline transgenesis and sustained transgene expression in pigs by using the Sleeping Beauty (SB) transposon system. The protocol is based on co-injection of a plasmid encoding the SB100X hyperactive transposase, together with a second plasmid carrying a transgene flanked by binding sites for the transposase, into the cytoplasm of porcine zygotes. The transposase mediates excision of the transgene cassette from the plasmid vector and its permanent insertion into the genome to produce stable transgenic animals. This method compares favorably in terms of both efficiency and reliable transgene expression to classic pronuclear microinjection or somatic cell nuclear transfer (SCNT), and it offers comparable efficacies to lentiviral approaches, without limitations on vector design, issues of transgene silencing and the toxicity and biosafety concerns of working with viral vectors. Microinjection of the vectors into zygotes and transfer of the embryos to recipient animals can be performed in 1 d; generation of germline-transgenic lines by using this protocol takes ∼1 year.

Indexed as

Animals, Genetically ModifiedDNA Transposable ElementsGene Transfer TechniquesAnimalsFemaleGenetic VectorsGenomeGerm CellsMaleMicroinjectionsSwineTransposasesDNA Transposable ElementsTransposases

Identifiers

PMID24625780
OpenAlexW2084962918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.